Orgenesis Inc reports results for the quarter ended in December - Earnings Summary

Orgenesis

21/03/2023 14:50

* Orgenesis Inc  ORGS.OQ  reported a quarterly adjusted loss
of 16
cents​​ per share for the quarter ended in December. The lone
analyst forecast for the quarter was for breakeven results per
share.
    * Revenue rose 97.7% to $13.62 million from a year ago;
analysts
expected $8.30 million. 
    * Orgenesis Inc's reported EPS for the quarter was a loss
of 16
cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Orgenesis Inc shares had fallen by 28.7% this quarter.
    * The company reported a quarterly loss of $1.27 million.
    * Wall Street's median 12-month price target for Orgenesis
Inc is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 21 at 02:50 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      0.00           -0.16          Missed
 Sep. 30 2022      -0.02          -0.05          Missed
 Jun. 30 2022      -0.02          -0.22          Missed
 Mar. 31 2022      -0.04          -0.16          Missed